Paper38540372
Multiplex Real-Time PCR-Based Newborn Screening for Severe Primary Immunodeficiency and Spinal Muscular Atrophy in Osaka, Japan: Our Results after 3 Years.
Kimizu T and 16 others. Genes (Basel), 2024. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. Multiplex Real-Time PCR-Based Newborn Screening for Severe Primary Immunodeficiency and Spinal Muscular Atrophy in Osaka, Japan: Our Results after 3 Years. Papers, record 38540372. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38540372
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Multiplex Real-Time PCR-Based Newborn Screening for Severe Primary Immunodeficiency and Spinal Muscular Atrophy in Osaka, Japan: Our Results after 3 Years.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neonatal Screening | Major topic |
| Muscular Atrophy, Spinal | Major topic |
| Infant, Newborn | |
| Humans | |
| Real-Time Polymerase Chain Reaction | |
| Homozygote | |
| Japan | |
| Sequence Deletion |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| JP19gk0110041 | Japan Agency for Medical Research and Development | PubMed | ||
| no | General Incorporated Association Nihon Shoni Senshin Chiryo Kyogikai | PubMed |
Source PubMed
References55
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35715566 | Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: the Phase III SPR1NT trial. | Nat Med | 2022 | https://conductscience.org/library/papers/35715566 | PubMed |
| 2 | 29943473 | Newborn screening using TREC/KREC assay for severe T and B cell lymphopenia in Iran. | Scand J Immunol | 2018 | https://conductscience.org/library/papers/29943473 | PubMed |
| 3 | 36892082 | Variability in Newborn Screening Across Canada: Spinal Muscular Atrophy and Beyond. | Can J Neurol Sci | 2024 | https://conductscience.org/library/papers/36892082 | PubMed |
| 4 | 12217331 | Clinical, immunological, and molecular analysis in a large cohort of patients with X-linked agammaglobulinemia: an Italian multicenter study. | Clin Immunol | 2002 | https://conductscience.org/library/papers/12217331 | PubMed |
| 5 | 34452804 | Epidemiological investigation of spinal muscular atrophy in Japan. | Brain Dev | 2022 | https://conductscience.org/library/papers/34452804 | PubMed |
| 6 | 3927169 | A uniform deleting element mediates the loss of kappa genes in human B cells. | Nature | 1985 | https://conductscience.org/library/papers/3927169 | PubMed |
| 7 | 36463459 | Newbornscreening SMA - From Pilot Project to Nationwide Screening in Germany. | J Neuromuscul Dis | 2023 | https://conductscience.org/library/papers/36463459 | PubMed |
| 8 | 33531827 | Spinal Muscular Atrophy: Mutations, Testing, and Clinical Relevance. | Appl Clin Genet | 2021 | https://conductscience.org/library/papers/33531827 | PubMed |
| 9 | 28711173 | Presymptomatic Diagnosis of Spinal Muscular Atrophy Through Newborn Screening. | J Pediatr | 2017 | https://conductscience.org/library/papers/28711173 | PubMed |
| 10 | 34321343 | Newborn screening for spinal muscular atrophy with disease-modifying therapies: a cost-effectiveness analysis. | J Neurol Neurosurg Psychiatry | 2021 | https://conductscience.org/library/papers/34321343 | PubMed |
| 11 | 16233029 | Development of a novel method for operating magnetic particles, Magtration Technology, and its use for automating nucleic acid purification. | J Biosci Bioeng | 2001 | https://conductscience.org/library/papers/16233029 | PubMed |
| 12 | 35317378 | Multiplex PCR-Based Newborn Screening for Severe T and B-Cell Lymphopenia: The first Pilot Study in Turkey. | Sisli Etfal Hastan Tip Bul | 2021 | https://conductscience.org/library/papers/35317378 | PubMed |
| 13 | 37222861 | Cost-Effectiveness of Newborn Screening for Spinal Muscular Atrophy in England. | Neurol Ther | 2023 | https://conductscience.org/library/papers/37222861 | PubMed |
| 14 | 37771582 | Case report: IKZF1-related early-onset CID is expected to be missed in TREC-based SCID screening but can be identified by determination of KREC levels. | Front Immunol | 2023 | https://conductscience.org/library/papers/37771582 | PubMed |
| 15 | 31304419 | Newborn Screening for Severe Combined Immunodeficiency in the US: Current Status and Approach to Management. | Int J Neonatal Screen | 2017 | https://conductscience.org/library/papers/31304419 | PubMed |
| 16 | 35715567 | Onasemnogene abeparvovec for presymptomatic infants with three copies of SMN2 at risk for spinal muscular atrophy: the Phase III SPR1NT trial. | Nat Med | 2022 | https://conductscience.org/library/papers/35715567 | PubMed |
| 17 | 28676062 | Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy - a literature review. | Orphanet J Rare Dis | 2017 | https://conductscience.org/library/papers/28676062 | PubMed |
| 18 | 31704158 | Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study. | Neuromuscul Disord | 2019 | https://conductscience.org/library/papers/31704158 | PubMed |
| 19 | 33073034 | Assessment of Spinal Muscular Atrophy Carrier Status by Determining SMN1 Copy Number Using Dried Blood Spots. | Int J Neonatal Screen | 2020 | https://conductscience.org/library/papers/33073034 | PubMed |
| 20 | 15696101 | Development of population-based newborn screening for severe combined immunodeficiency. | J Allergy Clin Immunol | 2005 | https://conductscience.org/library/papers/15696101 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42662969 | Nationwide TREC/KREC-based newborn screening and clinical outcomes in Japan. | J Hum Immun | 2026 | https://conductscience.org/library/papers/42662969 | PubMed |
| 42496450 | Development of Clinical Pathways for Early Diagnosis and Management of SCID, SMA, and XLA Through Newborn Screening in Malaysia. | Int J Neonatal Screen | 2026 | https://conductscience.org/library/papers/42496450 | PubMed |
| 41009951 | Editorial: Special Issue "Genetic Newborn Screening". | Genes (Basel) | 2025 | https://conductscience.org/library/papers/41009951 | PubMed |
| 39973413 | Newborn screening and rapid genomic diagnosis of neuromuscular diseases. | J Neuromuscul Dis | 2025 | https://conductscience.org/library/papers/39973413 | PubMed |
| 39836836 | First pilot study for newborn screening of severe T and B lymphopenias in Colombia | Biomedica | 2024 | https://conductscience.org/library/papers/39836836 | PubMed |
| 39596667 | A Modular Genetic Approach to Newborn Screening from Spinal Muscular Atrophy to Sickle Cell Disease-Results from Six Years of Genetic Newborn Screening. | Genes (Basel) | 2024 | https://conductscience.org/library/papers/39596667 | PubMed |
| 39500858 | Comprehensive newborn screening for severe combined immunodeficiency, X-linked agammaglobulinemia, and spinal muscular atrophy: the Chinese experience. | World J Pediatr | 2024 | https://conductscience.org/library/papers/39500858 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| SMN1 | 6606 | PubTator's text mining | https://conductscience.org/library/genes/6606 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38540372
GET https://conductscience.org/api/papers/v1/38540372/references?page=2